Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, interviews Patrick Forde, MD (MB, BCH), at the 2022 AACR meeting about his findings on immunotherapy in early-stage lung cancer.
You are about to leave the Patient Gateway
You’re one click away from learning about one of our most valued sponsors. Read about how they’re making a difference in patients’ lives.
